Whether patients with advanced tubo‐ovarian high‐grade serous cancer (HGSC) fare better after upfront debulking surgery (UDS) or neoadjuvant chemotherapy with interval debulking surgery (NACT‐IDS) remains controversial. Click to show full abstract
Whether patients with advanced tubo‐ovarian high‐grade serous cancer (HGSC) fare better after upfront debulking surgery (UDS) or neoadjuvant chemotherapy with interval debulking surgery (NACT‐IDS) remains controversial.
               
Click one of the above tabs to view related content.